Latest: Choosing the best UPLC system for your application – quaternary versus binary systems
Latest: New diagnostics technology platform connects data across hospital systems to improve...
Latest: Our mission to prevent Zika virus outbreaks
Latest: Plant DNA analysis: preventing the brown, maintaining the green
Latest: Rigaku presents latest XRM and CT analytical instrumentation at 2019 Microscopy &...
Latest: Detective in Golden State Killer case to open ISHI 2019 conference
Latest: ZEISS Introduces Enhanced Capabilities for Ion Beam Microscopes
Our mission to prevent Zika virus outbreaks
Next-Generation Immunotherapy: Combining Virus-Specific T Cells with Other Immuno-Oncology...
AI disaster mitigation technology to predict river flooding with limited data
FDA approves new device to improve symptoms in patients with advanced heart failure
3D high-content analysis: An emerging solution for drug discovery
Choosing the best UPLC system for your application – quaternary versus binary systems
Differential staining in biological tissue
Speed up your cannabis testing with Sartorius solutions
Analysis of aqueous mobile phase sample preparation and filtration steps in cannabis analytical...
Go digital within one week in three easy steps
eLABInventory: Bringing tomorrow's ideas into today's lab
Optimization of the PowerSoil®-htp 96 Well Soil DNA Isolation Kit on epMotion® 5075 VAC
CAR-T Cell Therapy Workflows
Hematology Analyzers & Stainers
Clinical Chemistry Analyzers
30 Oct 19 - 31 Oct 19
ELRIG Drug Discovery 2019
05 Nov 19 - 06 Nov 19
25 Jan 20 - 29 Jan 20
LGC has established itself as a world-class leader in biopharmaceutical drug development through analytical excellence with over 200 scientists across three UK facilities. Read more...
As regulatory pressure increases on pharmaceutical companies to investigate the potential interaction between a dosage form and the components of the primary closure and transfer system employed, leachables and extractables studies are be... Read more...
LGC is highly experienced in the application of a broad range of material characterisation techniques and packages and has the knowledge to support your product development from discovery to product registration and beyond. Read more...
Within the pharmaceutical sector, there is an increasing regulatory requirement for the characterisation and counting of visible and sub-visible foreign particles in pharmaceutical products from a safety, quality and efficacy perspective. Read more...
Bringing together Axolabs, Biosearch Technologies and the broader analytical and bioanalytical capabilities available across the company, LGC has a unique heritage and expertise in the development oligonucleotide therapeutics and nucleic ... Read more...
ProBioGen holds a manufacturing authorization for GMP (Good manufacturing practice) compliant manufacturing and batch release of biotechnological drug substances and fulfills all present regulatory requirements by EMA and FDA.
GMP Man... Read more...
Ready 4 Action, proprietary feasibility assessment, sets the cornerstone of a cost-effective product development plan.
Ready 4 Action is the four-step process used to evaluate the viability of proposed drug products. This important to... Read more...
Camargo ensures the appropriate regulatory requirements are met every step of the way, streamlining your drug development process all the way to approval. Ready to guide you through the preclinical stage of drug development, Camargo pr... Read more...
Superior Regulatory Service Helps Transform Your Clinical Trials.
Strong regulatory strategies are pivotal in getting products to market. While many countries’ drug regulations are similar, there are still significant differences. The... Read more...